Predicted protein targets (top 19)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LTA4H | P09960 | 3/20 | 0.41 |
| ▸ | TSHR | P16473 | 1/20 | 0.41 |
| ▸ | CA4 | P22748 | 1/20 | 0.38 |
| ▸ | MAOA | P21397 | 1/20 | 0.37 |
| ▸ | CA1 | P00915 | 2/20 | 0.36 |
| ▸ | CA2 | P00918 | 2/20 | 0.36 |
| ▸ | CA9 | Q16790 | 2/20 | 0.36 |
| ▸ | TAAR1 | Q96RJ0 | 1/20 | 0.36 |
| ▸ | KCNA3 | P22001 | 1/20 | 0.35 |
| ▸ | MAOB | P27338 | 1/20 | 0.33 |
| ▸ | CA5A | P35218 | 1/20 | 0.33 |
| ▸ | CA5B | Q9Y2D0 | 1/20 | 0.33 |
| ▸ | IDO1 | P14902 | 1/20 | 0.33 |
| ▸ | AGXT | P21549 | 1/20 | 0.32 |
| ▸ | NR1H2 | P55055 | 1/20 | 0.32 |
| ▸ | BAX | Q07812 | 1/20 | 0.32 |
| ▸ | SOS1 | Q07889 | 1/20 | 0.31 |
| ▸ | PARP10 | Q53GL7 | 1/20 | 0.31 |
| ▸ | SCN4A | P35499 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8885 | 0.83 | LTA4H (0.50) | LTA4HTSHRCA4MAOACA1 | |
| Hydrochloric Acid SCHEMBL693111 | 0.80 | LTA4H (0.47) | LTA4HTSHRCA4MAOACA1 | |
| SCHEMBL29544396 | 0.78 | LTA4H (0.45) | LTA4HTSHRCA4MAOACA1 | |
| SCHEMBL4735958 | 0.74 | CA4 (0.50) | LTA4HTSHRCA4MAOACA1 | |
| SCHEMBL449851 | 0.74 | LTA4H (0.63) | LTA4HTSHRMAOACA1CA2 | |
| SCHEMBL852456 | 0.74 | LTA4H (0.41) | LTA4HTSHRCA4MAOACA1 | |
| SCHEMBL4531186 | 0.74 | CA4 (0.43) | LTA4HTSHRCA4MAOACA1 | |
| SCHEMBL4697871 | 0.74 | LTA4H (0.41) | LTA4HTSHRCA4MAOACA1 | |
| SCHEMBL1162702 | 0.74 | LTA4H (0.41) | LTA4HTSHRCA4MAOACA1 | |
| SCHEMBL28166668 | 0.73 | TAAR1 (0.41) | LTA4HTSHRCA4MAOATAAR1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 150 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-111788484-B | Method for stabilizing protein contained in sample, solution for stabilizing protein contained in sample | 荣研化学株式会社 | 2024-11-19 | — | — | CN | claimed |
| EP-4421168-A2 | LARGE-SCALE PRODUCTION OF SOLUBLE HYALURONIDASE | Halozyme, Inc. (US) | 2024-08-28 | — | — | EP | claimed |
| EP-4269578-B1 | SOLUBLE HYALURONIDASE COMPOSITION | HALOZYME INC (US) | 2024-06-05 | — | — | EP | claimed |
| EP-4269578-A1 | LARGE-SCALE PRODUCTION OF SOLUBLE HYALURONIDASE | Halozyme, Inc. (US) | 2023-11-01 | — | — | EP | claimed |
| CN-111774111-B | Micro-fluidic chip for detecting glycosylated hemoglobin and detection method thereof | 上海佰芯生物科技有限公司 | 2023-04-11 | — | — | CN | claimed |
| CN-113136020-B | Water-based polyurethane polymer and preparation method thereof, single-component water-based polyurethane waterproof coating and preparation method and application thereof | 万华化学集团股份有限公司 | 2022-08-05 | — | — | CN | claimed |
| CN-113136020-A | Water-based polyurethane polymer and preparation method thereof, single-component water-based polyurethane waterproof coating and preparation method and application thereof | 万华化学集团股份有限公司 | 2021-07-20 | — | — | CN | claimed |
| CN-111774111-A | Micro-fluidic chip for detecting glycosylated hemoglobin and detection method thereof | 上海佰芯生物科技有限公司 | 2020-10-16 | — | — | CN | claimed |
| US-9493652-B2 | Polymeric film composition for non-enzymatic glucose sensor and non-enzymatic glucose sensor including the same | SAMSUNG ELECTRONICS CO., LTD. (KR) | 2016-11-15 | — | — | US | claimed |
| US-20150144486-A1 | POLYMERIC FILM COMPOSITION FOR NON-ENZYMATIC GLUCOSE SENSOR AND NON-ENZYMATIC GLUCOSE SENSOR INCLUDING THE SAME | INSTITUTE FOR RESEARCH & INDUSTRY COOPERATION, PNU (KR) | 2015-05-28 | — | — | US | claimed |
| EP-2268805-B1 | LARGE-SCALE PRODUCTION OF SOLUBLE HYALURONIDASE | HALOZYME INC (US) | 2015-05-06 | — | — | EP | claimed |
| US-8702931-B2 | Low cost electrochemical disposable sensor for measuring glycated hemoglobin | INDIAN INSTITUTE OF SCIENCE (IN) | 2014-04-22 | — | — | US | claimed |
| US-20120261257-A1 | LOW COST ELECTROCHEMICAL DISPOSABLE SENSOR FOR MEASURING GLYCATED HEMOGLOBIN | INDIAN INSTITUTE OF SCIENCE (IN) | 2012-10-18 | — | — | US | claimed |
| US-8187855-B2 | Large-scale production of soluble hyaluronidase | HALOZYME, INC. (US) | 2012-05-29 | — | — | US | claimed |
| US-20110053247-A1 | LARGE-SCALE PRODUCTION OF SOLUBLE HYALURONIDASE | HALOZYME, INC. | 2011-03-03 | — | — | US | claimed |
| EP-2268805-A1 | LARGE-SCALE PRODUCTION OF SOLUBLE HYALURONIDASE | Halozyme, Inc. (US) | 2011-01-05 | — | — | EP | claimed |
| WO-2009111066-A1 | LARGE-SCALE PRODUCTION OF SOLUBLE HYALURONIDASE | HALOZYME, INC. (US) | 2009-09-11 | — | — | WO | claimed |
| US-4562251-A | Agarose derivatives of amino phenyl boronic acid | AMICON CORPORATION (US) | 1985-12-31 | — | — | US | claimed |
| US-20250222078-A1 | MODIFIED HYALURONIDASES AND USES IN TREATING HYALURONAN-ASSOCIATED DISEASES AND CONDITIONS | HALOZYME, INC. (US) | 2025-07-10 | — | — | US | disclosed |
| US-4562251-A | Agarose derivatives of amino phenyl boronic acid | AMICON CORPORATION (US) | 1985-12-31 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250222078-A1 | MODIFIED HYALURONIDASES AND USES IN TREATING HYALURONAN-ASSOCIATED DISEASES AND CONDITIONS | CD44, HPSE, ENGASE | LTA4H 165/4885TSHR 2946/4885CA4 395/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.